Stay updated on Pembrolizumab Plus Entinostat in Melanoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Plus Entinostat in Melanoma Clinical Trial page.

Latest updates to the Pembrolizumab Plus Entinostat in Melanoma Clinical Trial page
- Check6 days agoChange DetectedRemoved the Melanoma tag, the related topics header, and the MedlinePlus Genetics link from the page's related topics area. This changes the page's metadata and related-resource references without altering the main study content.SummaryDifference0.2%

- Check14 days agoChange DetectedThe page gained new navigation and help sections (including a recruitment notice and How to Read a Study Record, Common Questions, How to Join a Study) and related topic tags, with a Revision note updated to v3.6.0. The 'Intervention / Treatment' heading was removed.SummaryDifference0.6%

- Check21 days agoChange DetectedA new Revision: v3.5.5 tag was added, and several related-topic/navigation items were removed (including Melanoma, related topics:, and MedlinePlus Genetics), as well as the older Revision: v3.5.4 tag. This reflects a footer/navigation cleanup rather than any modification to the study content.SummaryDifference0.2%

- Check28 days agoChange DetectedThe page now includes explicit melanoma keywords and a MedlinePlus related topics entry. This addition helps users understand the study's focus and access related information more easily.SummaryDifference0.2%

- Check42 days agoChange DetectedA new Revision: v3.5.4 tag was added, and references to Melanoma, related topics, MedlinePlus Genetics, and Revision: v3.5.3 were removed, indicating a refresh of the page's versioning and topic references.SummaryDifference0.2%

- Check49 days agoChange DetectedNo textual changes were detected in the supplied change data; the page content appears unchanged based on the information given.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab Plus Entinostat in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Plus Entinostat in Melanoma Clinical Trial page.